Amprion Announces Granting of European Patents for Seed Amplification Assay Platform

Expanded patent portfolio aims to safeguard uniform usage and consistent results in laboratories dedicated to neurodegenerative disorders clinical research SAN DIEGO, Aug. 15, 2023 /PRNewswire/ — Amprion, a global leader in neurodegenerative disease diagnostics, continues to fortify its…

About the Author

has written 20664 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com